JATT II Acquisition Corp. JATT FINANCIAL
Company Overview
JATT II Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in healthcare and healthcare-related businesses. The company was incorporated in 2026 and is based in Westfield, New Jersey.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +16.90% |
| 6 Months: | - |
| 3 Months: | +17.13% |
| 1 Month: | -6.15% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)49.91 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | JATT JATT II Acquisition Corp. FINANCIAL | 12.28 | - | $95.78M | 0.00% | - | - | - | - |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2026 | Jun 2026 |
|---|---|---|
| Revenue | 0 | - |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 68.79K | - |
| Operating Income | -68.79K | -762.26K |
| EBITDA | -68.79K | - |
| Interest Expense | - | - |
| Pretax Income | -68.79K | - |
| Tax Provision | - | - |
| Net Income | -68.79K | -305.55K |
| Diluted EPS | -0.01 | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Jupiter Topco LLC | 6.41% | 500.00K | $6.13M |
| 2 | RA Capital Management, L.P. | 6.41% | 500.00K | $6.13M |
| 3 | Balyasny Asset Management LP | 6.41% | 500.00K | $6.13M |
| 4 | Great Point Partners LLC | 6.41% | 500.00K | $6.13M |
| 5 | Adar1 Capital Management, LLC | 5.36% | 417.72K | $5.12M |
| 6 | Atika Capital Management, LLC | 5.13% | 400.00K | $4.90M |
| 7 | Franklin Resources, Inc. | 5.13% | 400.00K | $4.90M |
| 8 | Citadel Advisors Llc | 4.10% | 319.99K | $3.92M |
| 9 | Farallon Capital Management LLC | 3.85% | 300.00K | $3.68M |
| 10 | Braidwell LP | 3.21% | 250.00K | $3.06M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for JATT
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Talawar Tx Inc. ("Talawar" or "Talawar Therapeutics"), a biotechnology company developing potentially best-in-class bispecific antibodies that pair independent immunology & inflammatory (I&I) disease drivers in a single therapy, targeting p…
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
The newly formed biotech will use the funds to take its eczema bispecific, TALA-125, through to Phase IIb proof-of-concept trials.
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
WESTFIELD, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- JATT III Acquisition Corp (the "Company") announced the closing of its initial public offering of 6,900,000 ordinary shares at an offering price of $10.00 per ordinary share on August 27, 2…
JATT III Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
WESTFIELD, N. J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- JATT III Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial pub…
JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering
WESTFIELD, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”) announced the closing of its initial public offering of 6,000,000 ordinary shares at an offering price of $10.00 per ordinary share on April 20, 20…
JATT — Frequently Asked Questions
What is the current share price of JATT II Acquisition Corp. (JATT)?
As of 2026-09-19 21:16 PDT, JATT II Acquisition Corp. (JATT) trades at $12.28 on NasdaqGM. Its 52-week range is $10.20 to $13.78.
What is the market capitalisation of JATT?
JATT II Acquisition Corp. (JATT) has a market capitalisation of $95.78M on NasdaqGM.
Is JATT a good stock to buy?
This page provides a data-driven analysis of JATT II Acquisition Corp. (JATT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.